Skip to Content
Merck
CN

HPLC Analysis of Lidocaine and Related Compound A and H on Purospher®STAR RP-18 endcapped

HPLC Analysis of Lidocaine and Related Compound A and H on Purospher®STAR RP-18 endcapped application for HPLC

Materials

related product

Product No.
Description
Pricing

Lidocaine

powder

Lidocaine Related Compound A

Pharmaceutical Secondary Standard; Certified Reference Material

Lidocaine Related Compound H

Pharmaceutical Secondary Standard; Certified Reference Material

used together

Product No.
Description
Pricing

Phosphoric acid

≥85 wt. % in H2O, ≥99.999% trace metals basis

CONDITIONS

column

Purostar RP18E 2MYM HI-HR100-2.1 mm (1.50648.0001)

mobile phase

[A] 95/5 water / acetonitrile in 0.1% phosphoric acid; [B] 5/95 water/acetonitrile in 0.1% phosphoric acid

gradient

0% B for 2 min, then 0% to 100% B in 10 min; 100% to 0% B in 0.1 min; hold at 0% B for 4.9 min.

flow rate

0.3 mL/min

pressure

4656 psi (321 bar)

column temp.

30 °C

detector

210 nm UV

injection

1 μL

sample

100 μg/mL of lidocaine, related compound A and H in acetonitrile

Description

Analysis Note

Lidocaine is a medication used to numb tissue in a specific area and does not affect other areas. Topically it can be used for reducing pain by irritations such as sunburn, poison ivy, insect bites, minor cuts or even hemorrhoids. It can also be used for local anesthetic with sedative, analgesic and cardiac depressant (antiarrhythmic drug) properties This application demonstrates reverse phase interactions in a simple gradient separating lidocaine and two of its related compounds using Cerilliant CRM′s for the related compounds.

Legal Information

Purospher is a registered trademark of Merck KGaA, Darmstadt, Germany